SCHEMBL6849448

SCHEMBL6849448

N=C(N)NC(N)C(=O)Nc1cccc2c1C(=O)c1ccccc1C2=O

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOA P21397 1/20 0.59
MAPT P10636 3/20 0.47
MAPK1 P28482 2/20 0.47
RAB9A P51151 2/20 0.47
L3MBTL1 Q9Y468 2/20 0.47
EGFR P00533 1/20 0.47
PABPC1 P11940 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
TDP1 Q9NUW8 1/20 0.47
ALDH1A1 P00352 3/20 0.44
MEN1 O00255 2/20 0.44
KMT2A Q03164 2/20 0.44
POLB P06746 1/20 0.44
GAA P10253 1/20 0.44
DNMT1 P26358 1/20 0.44
RAD52 P43351 1/20 0.44
SMARCA2 P51531 1/20 0.44
CDK4 P11802 1/20 0.44
CCND2 P30279 1/20 0.44
CYP1A2 P05177 2/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5560042 0.83 MAOA (0.64) MAOAMAPTMAPK1RAB9AL3MBTL1
SCHEMBL9511573 0.79 MAOA (0.71) MAOAMAPTMAPK1RAB9AL3MBTL1
SCHEMBL6849240 0.77 MAPT (0.58) MAOAMAPTRAB9ASMN1; SMN2ALDH1A1
SCHEMBL5563589 0.77 MAOA (0.55) MAOAMAPTMAPK1RAB9AL3MBTL1
SCHEMBL6852445 0.76 MAOA (0.56) MAOAMAPTMAPK1RAB9AL3MBTL1
SCHEMBL2601918 0.75 MAOA (1.00) MAOAMAPTMAPK1RAB9AL3MBTL1
SCHEMBL28044169 0.74 MAOA (0.64) MAOAMAPTMAPK1RAB9AL3MBTL1
SCHEMBL5804633 0.73 MAOA (0.68) MAOAMAPTMAPK1RAB9AL3MBTL1
SCHEMBL20892849 0.73 MAOA (0.62) MAOAMAPTMAPK1RAB9AL3MBTL1
SCHEMBL10530825 0.72 MAOA (0.66) MAOAMAPTMAPK1RAB9AL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6777564-B2 AS ANTITUMOR AGENTS INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) 2004-08-17 US claimed
US-20030149092-A1 Anthraquinone compound INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) 2003-08-07 US claimed
US-6777564-B2 AS ANTITUMOR AGENTS INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) 2004-08-17 US disclosed
US-20030149092-A1 Anthraquinone compound INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) 2003-08-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030149092-A1 Anthraquinone compound ANTXR2, AAAS, H1-0 MAOA 2399/4885MAPT 4646/4885MAPK1 709/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.